Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial

Table 2 Per protocol and intention to treat analyses in both groups

Analysis	Regimen	Eradication rate	OR (95% CI)	p
Per protocol	Clarithromycin group	64.66 (75/116)	0.63 (0.36–1.11)	0.11
Per protocol	Levofloxacin group	74.36 (87/117)	0.63 (0.36–1.11)	0.11
Intention to treat	Clarithromycin group	55.56 (75/135)	0.69 (0.42–1.13)	0.14
Intention to treat	levofloxacin group	64.44 (87/135)	0.69 (0.42–1.13)	0.14

ISSN: 1471-2334